000 01307 a2200373 4500
005 20250513221406.0
264 0 _c20010103
008 200101s 0 0 eng d
022 _a1091-4269
024 7 _a10.1002/1520-6394(2000)12:1<53::AID-DA8>3.0.CO;2-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeintraub, D
245 0 0 _aAmphetamine positive toxicology screen secondary to bupropion.
_h[electronic resource]
260 _bDepression and anxiety
_c2000
300 _a53-4 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aAmphetamine
_xurine
650 0 4 _aAntidepressive Agents, Second-Generation
_xpharmacokinetics
650 0 4 _aBipolar Disorder
_xcomplications
650 0 4 _aBupropion
_xpharmacokinetics
650 0 4 _aChromatography, Thin Layer
650 0 4 _aDepression
_xdrug therapy
650 0 4 _aFalse Positive Reactions
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoassay
650 0 4 _aInpatients
650 0 4 _aRecurrence
650 0 4 _aSubstance Abuse Detection
_xmethods
700 1 _aLinder, M W
773 0 _tDepression and anxiety
_gvol. 12
_gno. 1
_gp. 53-4
856 4 0 _uhttps://doi.org/10.1002/1520-6394(2000)12:1<53::AID-DA8>3.0.CO;2-4
_zAvailable from publisher's website
999 _c10945514
_d10945514